Leukaemia
Grant-supported education
Lead from the frontline: Optimizing first-line treatment selection in Ph+ ALL
Join experts Elias Jabbour, Hagop Kantarjian and Nicholas Short from the 2023 ASCO annual meeting as they discuss Ph+ ALL treatment options and gain 1 CME credit.